Patent · US Expired

Oral formulations of ubidecarenone in form of capsules

US5443842A · kind A · utility

20Cited by
9References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 1994
Grant dateAug 22, 1995
Priority date
Expiry dateMar 30, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceuticals formulations are described, in form of capsules ad oral use, containing as the active ingredient ubidecarenone, characterized in that the active ingredient is dispersed in a mixture of isopropyl myristate or isopropyl palmitate with polyethoxylated, hydrogenated or non hydrogenated, castor oils.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.